Podcasts about nhs confederation

In this special episode of Health on the Line, recorded live from NHS ConfedExpo 2025, host Matthew Taylor is joined by Channel 4's Victoria Macdonald and The Sunday Times' Shaun Lintern to reflect on two packed days of debate, insight, and networking. With almost 7,000 delegates and over 150 sessions, the trio discuss their key takeaways from the conference—including health secretary Wes Streeting's speech, Jim Mackey's leadership style at NHS England, and the emerging contours of the government's ten-year health plan.Health on the Line is an NHS Confederation podcast, produced by HealthCommsPlus. Hosted on Acast. See acast.com/privacy for more information.

HSJ editor Alastair McLellan sits down with NHS Confederation chief executive Matthew Taylor during this year's ConfedExpo conference, which has been happening at the same time as the Chancellor's spending review.They cover whether Labour may have hoped for more money for the health service, NHS reform (and the personalities involved), the cultural acceptance of the status quo in the NHS, and how Mr Taylor would advise Wes Streeting on avoiding further resident doctor strikes.

The budget cuts to integrated care boards and their impact are a shock to many across the health care system, but also an opportunity for leaders to implement changes in the fundamental structures of primary and secondary care. Could this be the moment to make the investment shift to primary and community services?To discuss the potential and pitfalls, Matthew is joined by Rory Deighton, director of the NHS Confederation's acute network, and Ruth Rankine, director of our primary care network.Our Leader In Six segment is with Daniel Elkeles, chief executive of NHS Providers. Hosted on Acast. See acast.com/privacy for more information.

Huge change in health and care: Integrated Care Boards must cut their budgets by 50%, and acute providers are expected to roll back 50% of corporate cost growth since 2020. This on top of NHS England winding down within two years and transitioning what remains into the Department for Health and Social Care. Matthew talks to two leaders navigating these challenges; Amanda Sullivan, Chief Executive of Nottingham and Nottinghamshire ICB and Foluke Ajayi, CEO of Airedale NHS Foundation Trust and Vice Chair of the NHS Confederation. Hosted on Acast. See acast.com/privacy for more information.

This week the team talks about the GP jobs' crisis after the BMA held a virtual rally last week to help the union shape its plans for how to address the job shortage facing salaried and locum GPs. They also explain the findings from GPonline's own survey of locum GPs that shows the impact this has had on rates of pay and the finances and wellbeing of those doctors affected.And they discuss GP premises following a report published last week by the NHS Confederation that suggested NHS Property Services, which owns a significant number of GP premises, should be scrapped.Our good news story this week is about practices in the north West which have received extra funding to help them develop research hubs.This episode was presented by GPonline editor Emma Bower, deputy editor Nick Bostock and senior reporter Kimberley Hackett. It was produced by Czarina Deen.Useful linksBMA reveals 'vital' GP contract priorities that could solve jobs crisisMost locum GPs struggling to find work as jobs crisis devastates incomeRegistrars delaying GP qualification because they can't find jobs, says LMCNew GPs are being 'muscled out' of the NHS, warns registrars leaderGovernment should abolish NHSPS and pay off GP service charges, report suggestsGP practices share nearly £1m fund to expand research hubs Hosted on Acast. See acast.com/privacy for more information.

Unlock the secrets to revolutionising general practice with Ruth Rankine from the NHS Confederation, as she guides us through the intricate web of healthcare innovation and policy shaping. Learn how Ruth's pivotal role empowers her to engage with key stakeholders to drive transformative changes across the healthcare landscape. Discover the unique position of the NHS Confederation compared to the General Practitioners Committee, with a focus that extends beyond individual practices to embrace a diverse array of primary care providers. Ruth offers a candid look at the current landscape of general practice, highlighting the dynamic challenges and opportunities healthcare providers face amidst evolving governmental policies. With a focus on strategic co-production, community infrastructure, and organisational development, this episode offers valuable insights into the future of primary care and the path towards creating a resilient healthcare system. Introduction (00:09) A day in Ruth's life.. (01:18)  Influencing on behalf of members (02:37)  The difference between you & the GPC? (03:53) The current situation for General Practice (05:02)  What does the government want from General Practice? (07:20) General Practice & Neighbourhood teams.. (11:46) Coordination of organisations.. (14:03) How will collaborations work for local systems? (16:59) Do collaborations exist everywhere? (21:08)  Next steps.. (23:03)  Getting in touch.. (25:13) Visit the NHS Confederation website here. For all enquiries about the Ockham podcast, please contact Ben Gowland here.

This week Emma speaks to Ruth Rankine, director of primary care at the NHS Confederation, about how to create a neighbourhood NHS and the role general practice will play.A key plank of the government's plans is a move towards a neighbourhood NHS with more care provided outside hospital and in the community, but what does this mean in practice? ICBs are already working to set up integrated neighbourhood teams, but as yet there is no clear definition of what these teams should look like.In this conversation Ruth explains how this work is going, how the NHS will need to change if it is going to deliver more services in primary care, and the importance of allowing local areas the flexibility to redesign care in a way that meets the needs of their population.She also talks about how the GP contract may need to change in future to deliver this vision, the important role primary care networks have to play and the opportunities to create new pathways involving GPs with extended roles.This episode was presented by GPonline editor Emma Bower. It was produced by Czarina Deen.Useful linksGP contract and funding reform key steps towards 'neighbourhood NHS'NHS Confederation Primary Care NetworkNHS Confederation report - The case for neighbourhood health and careWhat do GPs want from the 10-year NHS plan? Hosted on Acast. See acast.com/privacy for more information.

Guest: Matthew Winn, Chief Executive, Cambridgeshire Community Services NHS Trust and Norfolk Community Health & Care NHS Trust. Matthew Winn has been the NHS England national director for Community Health leading on virtual wards, NHS Long Term Plan for older people and integration with social care. He continues to advise NHSE England and the Government on intermediate care and rehabilitation. On behalf of partners, he is the senior responsible officer across Bedfordshire and Luton for community health and integrated discharge and chairs the children and young people partnership in Cambridgeshire and Peterborough and is a core member of the Board developing the children's physical and mental health services across Norfolk. Previously he has chaired the regional research collaborative board (NIHR), founded and was the first chair of the Community Network (NHS Providers and NHS Confederation) and has been a member of the NHS Employers policy Board, Outside of work he can be found pounding his way around a real tennis court and providing support to Cambridge United Community Trust as a trustee. Join us as we discuss employee engagement in the NHS. Host: Jo Dodds

In this, the third of our conversations around AI in speech and language therapy, we look at AI as a tool for people who have aphasia - a language disorder that affects a person's ability to speak and understand. Caitlin Longman, Accessibility Lead at the Stroke Association tells us about her work with people with aphasia and we hear from some of them about how they are using AI and also what are their concerns. Dr Abi Roper, an academic speech and language therapist and self-confessed 'techy' tells us about her research into AI to support aphasia.Interviewees:Caitlin Longman, Accessibility Lead at the Stroke Association, guest lecturer at Strathclyde University.Abi Roper, Speech and Language Therapy research fellow at City University and Joint chair of the Computers in Therapy CEN.Resources:For RCSLT Members only:Artificial Intelligence resources: www.rcslt.org/members/delivering…ligence-resources/Integrating Generative AI in speech and language therapy: a practical guide www.rcsltcpd.org.uk/lessons/ai-in-slt/Open access:Computers in Therapy CEN (‘CITCEN') citcen.org/Co-Pilot copilot.microsoft.com/ChatGPT chatgpt.com/Image gen Free AI Image Generator - Image Creator in BingFactsheets from AbilityNet about AI abilitynet.org.uk/factsheets/what-…-how-do-i-use-itFree webinar from AbilityNet about how AI can help disabled people abilitynet.org.uk/webinars/how-can…-disabled-peopleWebinar series from the Health Foundation about AI and the NHS (exploring priorities and anticipating the future) www.health.org.uk/about-the-health…re-of-healthcareA guide from the NHS Confederation on AI: "AI in healthcare: navigating the noise". www.nhsconfed.org/publications/ai-healthcareBlog from NHS England ‘How artificial intelligence is helping to speed up the diagnosis and treatment of stroke patients'. www.england.nhs.uk/blog/how-artifi…troke-patients/Research:AI technologies in therapy - experiences and perceptions of SLPsSuh, H., Dangol, A., Meadan, H., Miller, C. A., & Kientz, J. A. (2024, June). Opportunities and challenges for AI-based support for speech-language pathologists. In Proceedings of the 3rd Annual Meeting of the Symposium on Human-Computer InteracPlease be aware that the views expressed are those of the guests and not the RCSLT.Please do take a few moments to respond to our podcast survey: uk.surveymonkey.com/r/LG5HC3R

Guest: Matthew Winn, Chief Executive, Cambridgeshire Community Services NHS Trust and Norfolk Community Health & Care NHS Trust. Matthew Winn has been the NHS England national director for Community Health leading on virtual wards, NHS Long Term Plan for older people and integration with social care. He continues to advise NHSE England and the Government on intermediate care and rehabilitation. On behalf of partners, he is the senior responsible officer across Bedfordshire and Luton for community health and integrated discharge and chairs the children and young people partnership in Cambridgeshire and Peterborough and is a core member of the Board developing the children's physical and mental health services across Norfolk. Previously he has chaired the regional research collaborative board (NIHR), founded and was the first chair of the Community Network (NHS Providers and NHS Confederation) and has been a member of the NHS Employers policy Board, Outside of work he can be found pounding his way around a real tennis court and providing support to Cambridge United Community Trust as a trustee. Join us as we discuss employee engagement in the NHS. Listen Live (Archive Available) Host: Jo Dodds

In this week's Health on the Line, Matthew speaks to Stephanie Cartwright, Group Director of Place for Walsall Healthcare NHS Trust and the Royal Wolverhampton NHS Trust, leading the place based partnerships in the Black Country ICS. Steph talks about the power and potential of work at Place level and what's happening in her area, as well as the new report published by the NHS Confederation on the State of Integration at Place.Matthew also brings us another of his quick fire 'Leader in 6' interviews with Tracey Bleakley, ICB CEO for Norfolk and Waveney.We'd love to hear your thoughts on our podcast. Please take five minutes to fill in this short survey: https://www.nhsconfed.org/HOTL Hosted on Acast. See acast.com/privacy for more information.

Health secretary Wes Streeting has set out three big shifts the NHS must deliver – including moving from analogue to digital. National strategy on health technology and digital is developing at pace, with a 10-Year Plan for the NHS expected to set out new priorities in the spring. We've seen no shortage of initiatives, roadmaps and plans for tech and innovation in recent years – yet delivery has often lagged behind. Today, acute pressures on health and care services, demographic headwinds and trends in disease burden mean there's an imperative to deliver at pace. Much recent attention has focused on AI and its revolutionary potential, but leveraging this depends on a range of other digital capabilities that not all NHS trusts and services have.  So, where is the NHS on its journey to digitisation? And, given all of this, what will it take for the NHS to become a truly digital health system?    To discuss, our Chief Executive Jennifer Dixon is joined by: Holly Krelle, Assistant Director at the Center for Healthcare Innovation & Delivery Science at New York University's Langone Medical Center. Erik Mayer, Consultant Surgeon at Imperial College Healthcare and the Royal Marsden NHS trusts, and Director of Imperial's clinical analytics unit.  Show notes Darzi et al (2024). Independent investigation of the NHS in England.   The Health Foundation (2025). Briefing on digital maturity in the NHS [forthcoming].   The Health Foundation (2023). What do technology and AI mean for the future of work in health care? Horwitz & Krelle (2023). Using rapid randomised trials to improve health care systems. Annual Review of Public Health.  Honeyford et al (2022). Challenges and recommendations for high quality research using EHRs. Frontiers in Digital Health. NHS Confederation (2024). Frontline digitisation: creating the conditions for a digital NHS.  Dearing & Cox (2018). Diffusion of innovations theory, principles and practice. Health Affairs. 

The recently released CQC (Care Quality Commission) review has highlighted systemic failings in how the organisation operates. We speak to the author Penny Dash, chair of North West London Integrated Care Board, about what went wrong, and what happens from here on? Also, in this podcast we find out about the NHS Confederation's recent report on the future of Neighbourhood Health. What does effective community engagement look like from a health perspective?Read our response to CQC review here: https://www.nhsconfed.org/news/nhs-confederation-responds-interim-report-care-quality-commissionOur report "Working better together in neighbourhoods": https://www.nhsconfed.org/publications/working-better-together-neighbourhoodsAnd we'd love to hear your thoughts on our podcast. Take five minutes to fill in this short survey: https://www.nhsconfed.org/HOTL Hosted on Acast. See acast.com/privacy for more information.

With integrated care systems now just over two years old, how effective are they in succeeding at their goals, and what needs to change for them to be more effective in the coming years? Matthew Taylor talks to Dr Kathy McLean OBE, chair of the NHS Confederation's ICS Network and NHS Derby and Derbyshire Integrated Care Board, as we release our State of Integrated Care Systems in 2023/24 report. Before that, Matthew speaks to Bridget Gorham, health economics policy adviser at the NHS Confederation, as new research highlights the economic imperative of investing in women's health services. An additional £1 invested in obstetrics and gynaecology services per woman in England could generate a staggering £319 million return to the economy. We'd love to find out what you think about the podcast. If you could spare just five minutes, fill in this short survey and send us your views. Hosted on Acast. See acast.com/privacy for more information.

In this episode, Nicole McGlennon, Managing Director of Health Innovation East Midlands, is joined by Dr Amit Aggarwal, Executive Director of Medical Affairs and Strategic Partnerships at the Association of the British Pharmaceutical Industry (ABPI). Dr Amit shares more about the ABPI's mission to make the UK the best place to research, develop and use the medicines of the future and explains the importance of the pharmaceutical industry to the UK and its economic benefit The discussion shares examples of collaborative working across the innovation ecosystem and the barriers to adopting innovation.    It also covers a new piece of guidance which the ABPI has launched, in partnership with NHS Confederation, on how to develop effective industry partnerships - a practical how-to guide both for companies and NHS organisations about how you can set up a partnership. You can find the guidance here. 

With economic inactivity at an all-time high, how can national and local systems unlock the potential of millions who would like to work if they had the right support and employment opportunities? To consider the issues, Matthew Taylor is joined by Rt Hon Alan Milburn, former health secretary under Tony Blair. As chair of the pioneering Pathways to Work Commission, he calls for a rethink of how the NHS is perceived, arguing that its power to drive economic growth should be a core component of future health and economic policy. Matthew also speaks to Michael Wood, the NHS Confederation's head of health economic partnerships, about the new government's ambitions in this area, including the WorkWell initiative set to begin in October 2024. Hosted on Acast. See acast.com/privacy for more information.

Just over two years on from their formal establishment, integrated care systems (ICSs) are continuing to contend with a range of challenges. But green shoots are emerging and the opportunities before them are starting to be more fully explored. Paul Mears, chief executive of Cwm Taf Morgannwg Health Board in Wales and former chief executive of Yeovil District Hospital in Somerset, talks to Matthew Taylor about his experiences working within ICSs and in Wales. Reflecting on managing demand, emergency care models, local collaboration and community care, he offers his view on what will support systems to thrive.Plus, Chris Thomas returns to explore how systems can unleash health and prosperity throughout Britain. Sharing findings from a new joint report, Chris, head of the IPPR's Commission on Health and Prosperity, considers what's needed to shift the dial on healthy life expectancy.This resource has been developed for relevant UK healthcare decision makers and stakeholders. The NHS Confederation is responsible for the editorial content of this resource. This resource forms part of a Collaborative Working Agreement between Novartis Pharmaceuticals UK Ltd and the NHS Confederation. Funding for the Collaborative Working Agreement and this podcast is provided by Novartis Pharmaceuticals UK Ltd.The views and opinions expressed are those of the speakers only.UK | MLR ID: FA-11248088 | August 2024 Hosted on Acast. See acast.com/privacy for more information.

Prime Minister Keir Starmer has confirmed the government is looking at tougher rules on outdoor smoking to reduce the number of preventable deaths linked to the habit and relieve pressure on the NHS.   The government has yet to confirm exactly what the changes could look like, but smoking could soon be banned in pub gardens, outdoor restaurants, and outside hospitals and sports grounds.     Host Liz Bates heads to one of Westminster's most famous pubs to explore why Labour are planning these changes, with our chief political correspondent Jon Craig.      The NHS Confederation's Dr Layla McCay explains the impact extending the smoking ban could have not just on public health, but on the economy as well, and Kate Nicholls from UKHospitality tells us the concerns her industry has about the proposals.   Producer: Emma Rae Woodhouse & Rosie Gillott Editor: Paul Stanworth Promotions producer: Jada-Kai Meosa John 

In this episode of the Carbon Copy Podcast Running Out of Time special, we rejoin the climate relay as the baton reaches Worcester. We hear from Dan Brothwell and Rob Collier, founders of Bike Worcester, about their passion for make cycling more accessible for all. We also learn about sustainability at the University of Worcester, from Professor Sally Moyle and Katy Boom, in a conversation with Chair of the NHS Confederation, Lord Victor Adebowale. Listen to hear how the next generation is inspiring all the guests in this episode to take action for a more sustainable future. “I'm 62 and it seems that our generation really had a bit of a party. You know, [sustainability] wasn't that big an issue… We've had a great time, and now the generation that are running out of time have got five years basically to make a significant difference to the trajectory. Otherwise, they're going to be living in a depleted world… “…We had the party, but we're expecting them to get in the kitchen and clean up afterwards, and actually, I'm surprised they're not more frustrated or more angry than they are because this is their lives and their kids' lives. So we have a duty to make this an issue, to listen to them and help them tell the story and get the message across.” - Lord Victor Adebowale -------------------------------------------------------------- Show Notes Find out more about what's happening across Worcester for climate and nature, here: www.carboncopy.eco/local-climate-action/worcester Learn more about Bike Worcester: https://carboncopy.eco/initiatives/bike-worcester Listen to the full Bike Worcester No Foot Down podcast: https://open.spotify.com/show/14suTArgU6nEjyD6WgOsr1?si=fd6f3be36f8c4452 Read more about the SHIFT scheme in Worcester: https://goshift.co.uk/ Read about sustainability work taking place at the University of Worcester: https://www.worcester.ac.uk/about/sustainability/ Read about the work the NHS Confederation is doing to tackle the climate crisis: https://www.nhsconfed.org/topic/climate-change Learn about Lord Victor Adebowale: https://www.nhsconfed.org/people/victor-adebowale-cbe Sign up for a leg of the Running Out of Time relay: https://running-out-of-time.com/route Hosted on Acast. See acast.com/privacy for more information.

David interviews Dr Layla McCay, Director of Policy at the NHS Confederation, psychiatrist, and author of the recent non fiction hit 'Breaking The Rainbow Ceiling'. Layla shares the challenges facing LGBTQ+ professionals as they navigate their careers and we explore some of her most treasured reads. This is the third episode in our Pride Month series.

This week's episode comes to you from the NHS ConfedExpo conference in Manchester, where we're joined by NHS Confederation's CEO Matthew Taylor and chair Victor Adebowale. We cover Amanda Pritchard's big speech and the reaction to it, the manifestos, the need for a new government to tackle capital spending, and more. With Annabelle Collins and Dave West. 

How can LGBTQ+ people thrive and succeed at work?There are currently only four LGBTQ+ CEOs across all Fortune 500 and FTSE 100 companies who are out at work, and just 0.8% of Fortune 500 board positions are filled by LGBTQ+ people. This deficit, occurring across sectors and around the world, reveals a diversity gap playing out in today's workplace: LGBTQ+ people are less likely to reach the top jobs. But what is holding LGBTQ+ people back at work – and what can be done?Layla McCay is Director of Policy at the NHS Confederation, Executive Lead of the UK's Health and Care LGBTQ+ Leaders Network and author of a new book: Breaking the Rainbow Ceiling. Combining fresh data with personal insights from over 40 prominent LGBTQ+ trailblazers, from CEOs to Ambassadors, the book reveals the challenges that LGBTQ+ people commonly encounter as they find their way in work environments, and provides practical strategies that can help empower LGBTQ+ people to reach their full professional potential.Join Layla at the RSA to explore how everyone – from boards, CEOs, HR professionals, managers and colleagues, through to LGBTQ+ people navigating their own career paths – can recognize and address the barriers to progression, achieve their career goals, and build a more inclusive workplace where everyone can thrive and succeed.#RSAPrideBecome an RSA Events sponsor: https://utm.guru/udI9xDonate to The RSA: https://utm.guru/udNNBFollow RSA Events on Instagram: https://instagram.com/rsa_events/Follow the RSA on Twitter: https://twitter.com/RSAEventsLike RSA Events on Facebook: https://www.facebook.com/rsaeventsofficialListen to RSA Events podcasts: https://bit.ly/35EyQYUJoin our Fellowship: https://www.thersa.org/fellowship/join

GUEST 1 OVERVIEW: Stephen Dorrell spent 36 years in Parliament, serving as Health Secretary under John Major and Chair of the House of Commons Health Committee from 2010 to 2014. After leaving Parliament, he chaired the NHS Confederation (2015-2019) and founded an advisory business on public service reform. A frequent commentator on healthcare, Stephen advocates for using digital technology to create more efficient and integrated health services. GUEST 2 OVERVIEW: Alex Zaharov-Reutt is TechAdvice.Life Editor. He's one of Australia's best-known technology journalists and consumer tech experts. Alex has appeared in his capacity as a technology expert on all of Australia's free-to-air and pay-TV networks on all the major news and current affairs programs, on commercial and public radio, and technology, lifestyle, and Reality TV shows. X: @alexonline888 GUEST 3 OVERVIEW: Dr. Kat Lindley is a Croatian-born and American-trained board-certified family physician in Texas with a direct primary care practice. She loves caring for the whole family and seeing the whole family grow. She also became interested in finding solutions to improve America's healthcare system. She is a Fellow of the American College of Osteopathic Family Physicians and is involved with many medical organizations, including GlobalHealthProject.org, GlobalCOVIDSummit.org, and the American Association of Pharmaceutical Scientists (AAPS).

Sam Freedman and Ayesha Hazarika sit down with the Chief Executives of the The King's Fund and NHS Confederation, Sarah Woolnough and Matthew Taylor, to discuss Labour's health pledge on waiting lists and what lies ahead.This week as the general election campaign hits full swing, and The Power Test is focused once again on one of the top issues for the voting public: The NHS.To find out more visit ThePowerTest.co.uk and become a Power Member so that you can access episodes early and ad-free. Hosted on Acast. See acast.com/privacy for more information.

Currently, there are only four LGBTQ+ CEOs in the Fortune 500 and none in the FTSE 100. This really illustrates the hidden challenges and differences in professional opportunities for LGBTQ+ people, especially when it comes to promotion and recruitment into senior roles. Many employers publically say that improving diversity and inclusion in their workforce is a significant priority, but this will only truly happen with appropriate representation at the top of the organization. My guest this week is Layla McCay, Director of Policy at the NHS Confederation and author of a new book called "Breaking The Rainbow Ceiling." Layla shines a light on the challenges that LGBTQ+ people face at work and offers advice on how companies can recognize and address the barriers and build a more inclusive workplace where everyone can thrive and succeed. In the interview, we discuss: Why she wrote the book The barriers that prevent LGBTQ+ people from being hired or promoted into senior roles Roles models and self-esteem Conscious and unconscious bias Managers reinforcing imposter syndrome. Understanding different experiences Allowing people to do their best work Intersectionality Equity in talent management Advice to employers on inclusive hiring Follow this podcast on Apple Podcasts.

Currently, there are only four LGBTQ+ CEOs in the Fortune 500 and none in the FTSE 100. This really illustrates the hidden challenges and differences in professional opportunities for LGBTQ+ people, especially when it comes to promotion and recruitment into senior roles. Many employers publically say that improving diversity and inclusion in their workforce is a significant priority, but this will only truly happen with appropriate representation at the top of the organization. My guest this week is Layla McCay, Director of Policy at the NHS Confederation and author of a new book called "Breaking The Rainbow Ceiling." Layla shines a light on the challenges that LGBTQ+ people face at work and offers advice on how companies can recognize and address the barriers and build a more inclusive workplace where everyone can thrive and succeed. In the interview, we discuss: Why she wrote the book The barriers that prevent LGBTQ+ people from being hired or promoted into senior roles Roles models and self-esteem Conscious and unconscious bias Managers reinforcing imposter syndrome. Understanding different experiences Allowing people to do their best work Intersectionality Equity in talent management Advice to employers on inclusive hiring Follow this podcast on Apple Podcasts.

Currently, there are only four LGBTQ+ CEOs in the Fortune 500 and none in the FTSE 100. This really illustrates the hidden challenges and differences in professional opportunities for LGBTQ+ people, especially when it comes to promotion and recruitment into senior roles. Many employers publically say that improving diversity and inclusion in their workforce is a significant priority, but this will only truly happen with appropriate representation at the top of the organization. My guest this week is Layla McCay, Director of Policy at the NHS Confederation and author of a new book called "Breaking The Rainbow Ceiling." Layla shines a light on the challenges that LGBTQ+ people face at work and offers advice on how companies can recognize and address the barriers and build a more inclusive workplace where everyone can thrive and succeed. In the interview, we discuss: Why she wrote the book The barriers that prevent LGBTQ+ people from being hired or promoted into senior roles Roles models and self-esteem Conscious and unconscious bias Managers reinforcing imposter syndrome. Understanding different experiences Allowing people to do their best work Intersectionality Equity in talent management Advice to employers on inclusive hiring Follow this podcast on Apple Podcasts.

Guest post by Layla McCay, who publishes Breaking the Rainbow Ceiling on 23rd May RRP £16.99 (Bloomsbury) If you were asked to name a prominent LGBTQ+ tech CEO, you might think of Tim Cook. When the Apple CEO came out publicly in 2014, he was the first leader of a Fortune 500 company to do so. This decision made waves. The visibility of an LGBTQ+ person succeeding in such a prominent role challenged prejudices. It made staff, employees and the general public think differently and it super-changed young queer people's career aspirations. How to deal with the Rainbow Ceiling Prior to that moment, and certainly in my own youth, we just hadn't seen LGBTQ+ people visibly, unapologetically succeeding in senior positions. We were more used to being whispered about or portrayed in negative ways. Having this successful, confident role model was different. Tim Cook's decision to come out changed perceptions about LGBTQ+ people at work in ways that are still reverberating. A decade later, you might assume that Cook's trailblazing would have opened the door to far more publicly out LGBTQ+ people in senior roles. But it has not. Today only three of the CEOs running America's five hundred biggest companies are publicly known to be LGBTQ+. And it's a trend we see repeated in board rooms around the world. The data tell us: disproportionately few LGBTQ+ people make it to the upper echelons of our careers - and this is nothing to do with our ability. The discrimination and other barriers that contribute to inequality in LGBTQ+ people's careers have largely been flying under the radar on board papers and on managers' priority lists for some time. But we only need to look at the research or to ask LGBTQ+ people about their personal stories and a pattern emerges. Most people are familiar with the concept of a 'glass ceiling', a metaphor typically used to describe how women are prevented from reaching the top jobs. It's less well known that there is also a rainbow ceiling. It's a barrier that does not affect everyone equally. Just as the rainbow rises up in an arc, the height of an individual's rainbow ceiling can be lower or higher according to factors like experiences growing up, societal prejudices of the day, and the culture that exists in different sectors and workplaces. The rainbow ceiling is often invisible to employers and sometimes even to the LGBTQ+ people who work under its constraints. Many tend to assume: "Oh, that was a problem in the old days, but it's fine now." The evidence tells us that it is not. A ceiling exists, and it still holds down LGBTQ+ people at work. There are two big reasons that this matters: breaking the rainbow ceiling is not just the fair thing to do; it can improve the performance of individuals and the overall performance of the organization. First, even in companies and countries that consider themselves strong on policies, legislation and culture that do not tolerate discrimination, there is still, right now, a difference in opportunity between LGBTQ+ people and our peers. This difference becomes more pronounced, though often unrecognized, as people climb the career ladder. Any leader committed to fairness should factor this particular challenge into their work. The second reason is that there is a compelling link the between diversity in the workplace, including on executive teams, and better recruitment and retention; problem solving and innovation; and ultimately, financial performance, including revenue and market share. If LGBTQ+ people are given a fairer chance to succeed in our careers, it makes things better for everyone. Ten years ago the tech sector led the way. Can it follow through? Layla McCay is Director of Policy at the NHS Confederation and Executive Lead of the national Health and Care LGBTQ+ Leaders Network. A psychiatrist and founder of the Centre for Urban Design and Mental Health, her co-authored book, Restorative Cities: Urban Design for Mental Health and Wellbeing, was a finalist for ...

Today's guest is not just a social business leader, he is also a policy wonk, a tech entrepreneur, and a crossbench (non political) Peer.     Born and bred in Wakefield, Victor dropped out of school and worked as a road sweeper before branching into council housing management and getting his first CEO role aged 24. He ran increasingly complex social enterprises and joined the House of Lords where he advocates important neglected issues. He currently sits on the board of the Co-op Group and chairs the NHS Confederation. He also chairs Visionable, a video and data tech platform designed to bring healthcare to everyone, everywhere.   Victor's chosen dish is one of comfort: Nigerian chicken stew. Growing up this was his Sunday lunch, and an opportunity for his parent's Yoruban roots to shine through in food.   It's a dish with many variations, and we explore the impatient cook's version along with the slower, more detailed way to cook it in part 2 of the episode.   Bon Appétit!   “Enjoy leadership and food because they don't last forever” – Victor Adebowale   You'll hear about:   02:06 – An introduction to Victor 12:26 – The inverse care law 15:26 – Why 9/11 was so important for Victor 18:30 – Politicians are in the wrong job 19:20 – Victor's desert island dish 24:33 – You can't cut your way to growth 29:49 – Why Empathy is a fundamental quality 40:31 – Part 2 – Nigerian Chicken Stew recipes 44:40 – The bish bash bosh version 48:21 – The advanced recipe   Episode resources:   Polpo: A Venetian Cookbook - https://rb.gy/wsd8py    Find out more about Victor:   LinkedIn - https://www.linkedin.com/in/loadebowale/  Visionable - https://visionable.com/    Contact François:   LinkedIn - https://www.linkedin.com/in/francoismoscovici/ Valentine's LinkedIn: https://www.linkedin.com/in/valentine-moscovici/    François' Instagram food feed: @moscoffier 

By the end of 2023, Barking, Havering and Redbridge University Hospitals NHS Trust had made the most improvement on waiting lists for emergency care than any other trust in England. How did they do it? In this episode, Matthew Taylor sits down with the trust's chief executive, Matthew Trainer, to find out more, and they get candid about leadership and improvement in testing times. Matthew details the challenges faced since taking up post in 2021 and how investment in management, staff engagement, primary and community care and digital transformation has supported the London trust's improvement journey.Plus, with the results of the mayoral elections now in, Matthew Taylor unpacks why they matter to the NHS. He is joined by the NHS Confederation's head of health economic partnerships, Michael Wood, who explains why metro mayors should be seen as ‘chief delivery officers' and why the country is becoming more accustomed to devolution. Hosted on Acast. See acast.com/privacy for more information.

Oxford University economist Kate Raworth has been described by the author and environmentalist George Monbiot as, "The John Maynard Keynes of the 21st century." In 2018, she came to Intelligence Squared to talk through the set of ideas that has seen her influential book, Donut Economics, find fans in audiences ranging from members of the UN General Assembly to Pope Francis and Extinction Rebellion. Hosting the discussion was Matthew Taylor, at the time of the interview Chief Executive of the RSA and latterly Chief Executive of the NHS Confederation. We are sponsored by Indeed. Go to Indeed.com/IS for £100 sponsored credit. If you'd like to become a Member and get access to all of our longer form interviews and Members-only content, just visit intelligencesquared.com/membership to find out more. For £4.99 per month you'll also receive: - Full-length and ad-free Intelligence Squared episodes, wherever you get your podcasts - Bonus Intelligence Squared podcasts, curated feeds and members exclusive series - 15% discount on livestreams and in-person tickets for all Intelligence Squared events - Our member-only newsletter The Monthly Read, sent straight to your inbox ... Or Subscribe on Apple for £4.99: - Full-length and ad-free Intelligence Squared podcasts - Bonus Intelligence Squared podcasts, curated feeds and members exclusive series ... Already a subscriber? Thank you for supporting our mission to foster honest debate and compelling conversations! Visit intelligencesquared.com to explore all your benefits including ad-free podcasts, exclusive bonus content and early access. ... Subscribe to our newsletter here to hear about our latest events, discounts and much more. https://www.intelligencesquared.com/newsletter-signup/ Learn more about your ad choices. Visit podcastchoices.com/adchoices

This episode is with leading health and care expert Nigel Edwards. Nigel recently stepped down as the chief Executive of the Nuffield Trust, a leading health think tank, after a wide-ranging career in the sector, which included a stint at NHS Confederation. This episode is very timely. Health and care services are adapting to a new structure at the same time as being under huge pressure and Nigel brings fantastic insight into what is currently happening within the system and what might change. We talk about the emphasis on “place” and “neighbourhoods” and the ambition for local services to be more co-ordinated, driven by local priorities and ultimately more focused on keeping people healthy and out of hospital. We ask the question – are leaders able to make time to build the relationships which are needed to enable this type of high trust working. We take a deep dive into children's health and discuss the ambitious plans Integrated Care Boards have for children's health and the fact that the NSH cannot possibly achieve them without working very closely with councils and other partners. We ask, what enabling leadership and conditions need to be in place to achieve these ambitions for children? None of these changes will have any effect unless the change permeates down to middle management and front line staff. We challenge the notion of the “frozen middle” or “permafrost” which is a criticism sometimes aimed at public sector middle managers and look at the potential of regional working and ask what the right level is for different activities. Enjoy it!

Matthew Taylor is the Chief Executive of the NHS Confederation. Here he gives his take on the challenges facing the NHS, the shortfalls in funding, the need for capital investment, the under-management of the health service, the choices facing politicians, the problems in social care, huge waiting lists, the cost analyses of prevention and innovation, the economics of an ageing population, junior doctors' pay and staff morale. This is a rare opportunity to learn more about a British institution during an election year. 

On today's episode of the G Word, our guests will be discussing the CanGene-CanVar programme. Funded by Cancer Research UK, the 5-year programme aims to create an interface between NHS clinical care and research that will expand genetic testing access for those with inherited cancers. Our host Amanda Pichini, Clinical Lead for Genetic Counselling at Genomics England, is joined by Dr Helen Hanson, Consultant in cancer genetics at the Peninsular Regional Genetic Service, Kelly Kohut, Lead Genetic Counsellor at the South West Thames Centre for Genomics, and Rochelle Gold, Patient Representative on the CanGene-Canvar research programme and co-founder of BRCA Journey.   "There is also the possibility of finding out genetic information that's familial or inherited, which could mean that the information is not only important for the person who is being treated for cancer at the current time but also as a next step informing relatives that they might have a higher chance of getting cancers in the future due to a genetic variant..."     You can read the transcript below or download it here: How-are-genetic-tests-transforming-cancer-prevention.docx   Amanda: Hello and welcome to The G Word.  My name is Amanda Pichini and I'm the Clinical Lead for Genetic Counselling at Genomics England.  We know that cancer is a very common disease.  About one in two people will develop cancer at some point in their lifetime.  Cancer is a disease of the genome involving many changes to a person's genome over time as well as other factors.  Only a small proportion of all cancers are inherited, but this can have a significant impact for those families who have a much higher risk of cancer and options to reduce their risk.    Today I'm delighted to be joined by Dr Helen Hanson, Consultant Clinical Geneticist; Kelly Kohut, Consultant Genetic Counsellor; and Rochelle Gold, Patient Representative and co-founder of BRCA Journey.  We'll be discussing the CanGene-CanVar programme which aims to link NHS clinical care and research to expand access to genetic testing and care for people with inherited cancers.  Welcome, Rochelle, Helen and Kelly to The G Word.  Thank you for joining me today.  Let's start with some introductions.  Rochelle, over to you?  Rochelle: Hi, everyone.  I'm Rochelle and I'm one of the Patient Reps on the CanGene-CanVar research programme.  I also co-founded an organisation called BRCA Journey that helps to raise awareness of the BRCA genetic mutation amongst both clinicians and the community, and also supports people who might be at risk of the mutation or who are thinking about testing, all the way through to maybe having preventative treatment or preventative surgery.  We support those with that decisions.  We're not genetic counsellors but we do basically talk to people about our experience and knowledge that we have of what it's like as a patient to be someone living with the mutation.    Amanda: Thank you.  Could you briefly tell us what BRCA is and how you came to be a patient?  Rochelle: BRCA is a genetic mutation that puts people at greater risk of breast and ovarian cancer.  My mum had the mutation, in fact she had two of the mutations which is apparently quite rare.  She passed away from breast cancer and just before she passed away I found out that I had the genetic mutation as well.  I personally have had preventative surgery and reconstruction to prevent myself from getting breast and ovarian cancer.  I got involved in being a patient rep so that I can advocate for people who may have the mutation, but also make sure that as many people as possible can be tested and be aware that they have the mutation and have that power to have the knowledge to be able to do something about it should they so wish.  Amanda: Thank you so much for sharing that with us.  Kelly, over to you?  Kelly: Hello, everyone.  I'm Kelly Kohut, I'm the Lead Consultant Genetic Counsellor at the South West Thames Centre for Genomics, which is based at St George's Hospital in London.  For many years I've been working in clinical practice in genetic counselling, seeing patients and their families regarding personal or family history of cancer, offering genetic testing where that's available, and then giving the results and helping to refer people on for surveillance programmes and to discuss risk reducing options, and also help a lot with communication within families, sharing the information from the genetic test results.    For the past few years, I've also been doing my own research as part of the CanGene-CanVar programme, funded by the charity Cancer Research UK.  This has involved partnering directly with patients and other expert stakeholders to co-design a patient website to support decision-making around the genetic chances of getting cancer in families.     Amanda: Thank you.  And Helen?  Helen: Hi, everyone.  I'm Helen Hanson, I'm a Consultant in Cancer Genetics.  I'm based at the Peninsular Regional Genetic Service which is in Exeter.  In my clinical practice I see patients who either have a cancer diagnosis to consider whether they may have an inherited susceptibility or people who maybe have a family history of cancer to try and determine if they are at risk due to their family history.  Like Kelly and Rochelle I've also been involved in the CanGene-CanVar programme for the last four years.  I've been involved in work package three of the programme which is developing clinical guidelines with the patients who have an inherited predisposition to cancer.  I was also fortunate enough to be given some funding to carry on with this work beyond the programme in the new NIHR Exeter Biomedical Research Centre.    Also, I'm currently chair of the UK Cancer Genetics Group, who has an aim of improving the management of patients who have an inherited predisposition to cancer.  It's been really great to work on all these different things and try and bring things together to try and improve care for patients who do have rare inherited genetic conditions predisposing to cancer.   Amanda: Fantastic.  Thanks, everyone.  Kelly, I wondered if you could start us off by just explaining a little bit more about how genetics and genomics is relevant to cancer.  Especially inherited cancers, why is this an important thing to talk about?  Kelly: The availability of genetic testing has been increasing steadily over the years.  Currently from pretty much anyone who's been diagnosed with cancer there should be some awareness around the possible benefit of knowing the genetics behind the development of that cancer and whether any genetic or genomic testing might help to choose more personalised treatments or surgical options for that cancer that's been diagnosed.  There is also the possibility of finding out genetic information that's familial or inherited, which could mean that the information is not only important for the person who is being treated for cancer at the current time but also as a next step informing relatives that they might have a higher chance of getting cancers in the future due to a genetic variant and that they could ask their GP for referral to genetics to be offered genetic testing and to find out about their chances of getting cancer and the choices for how to manage that.    Amanda: Thank you.  There are clearly some important things that someone would do differently when they know they have an inherited cancer.  Helen, how can we make sure that clinicians and patients and families know what do to in these situations?  Helen: Following on from Kelly explaining the amount of genetic testing we can offer has really increased over the last five to ten years and we're not in a position to offer many more patients genetic testing, it's important that we also consider what to do with that information when we discover somebody does have a pathogenic variant or a mutation in a cancer predisposition gene.  There are over 100 different cancer predisposition genes described and actually having a variant in one these genes is rare.  It's difficult and like other conditions in medicine due to their rarity to really understand how best to manage these patients.  But what's very important is that we try to understand how best we can help patients manage their cancer risk based on the lifetime risk of cancer and the particular cancers that they can develop and ensure that patients across the country are all being given the same advice, the same information about their cancer risks.    Through the CanGene-CanVar programme we've had a whole work package which is devoted to clinical guideline development where we've looked at a number of these genes and looked at the evidence that is available in terms of cancer risks, the utility of surveillance or early detection of cancers in that condition, and also whether risk-reducing surgery could be offered.  Really try to bring together groups of experts to discuss the evidence because for some genes it really is quite limited due to the rarity of the condition.  The overarching aim is really to develop guidance that is relevant and can be offered in our current clinical practice and is consistent to all patients who have a variant in one of these genes.  Amanda: You mentioned that many of these inherited cancer conditions are very rare. Is there a need to look internationally or collaborate internationally?  How do you pull some of these things together when there's so little information?    Helen: We definitely have found it really helpful to have international collaborations.  Some of these conditions there may be very few patients in the UK who have this condition, so each individual clinician who works in cancer genetics may have only seen one or two patients with the condition than themselves and, therefore, collaborating with international colleagues has been very helpful and we have recently published some guidance for a condition BAP1 tumour predisposition syndrome which increases an individual's lifetime risk of developing mesothelioma, which is a type of lung cancer, renal cancer and melanomas of the skin and eye.  This is a rare condition, but we worked with European colleagues to develop a set of guidelines advising what surveillance the patient should have, so looking to melanomas, looking for early detection of kidney cancers, so having that international collaboration has been really very helpful because in the UK there are so few cases per centre of individuals who have that condition.     Amanda: That sounds really helpful.  Rochelle, we know that shared decision-making is so important in healthcare.  How can we make sure that the voices of patients are reflected within these guidelines that were developing and that it's clear to them what needs to happen for their healthcare?     Rochelle: I think it's really important that patients are involved in the development of the guidelines, first of all, and actually within those guidelines there is stuff that talks about that, being about shared decision-making.  A lot of these guidelines are in a language that are quite a clinical language that is not necessarily accessible to patients themselves.  It's really important that they're part of the creation of them but also that there are things out there that enable people to understand what are these guidelines about, what do these guidelines actually mean in practice.  When you find out that you have a particular genetic mutation, of course, the first place you probably go is Google.  You find a hell of a lot of information and you find all sorts from different countries and different people and different organisations.  You're like which is the thing I need to look at, which is the thing that actually tells me what's going on, which is the thing that really helps me to understand what this actually means for me and what should happen to me?  What is the pathway for me, etc.    I think we also need to recognise that people have different levels of health literacy as well.  I am someone who can probably navigate my way around a very complex system, which is the NHS, maybe better than other people.  But there are plenty of people out there who this is new people, this is a completely new thing that's happened to them, a completely new thing to understand.  If you're not used to being part of health systems and navigating your way around it, it can be quite scary.  What does mutation mean?  What does it mean for me?  What does it mean to my future?  What does it mean for my family?  All this information.  There needs to be something somewhere that talks about this, some sort of lay way and helps people to understand what this means for them and helps them to engage with it.  To some extent, that's where my organisation was born from, that thing about having somebody who can just talk about it in normal words, in normal terms and normal views of what these guidelines actually do mean.  The fact is they are just guidelines, they don't tell you this is what you do.  You're this person, you're in this circumstance, you do this, it doesn't.  There's some ambiguity there that needs to be navigated by the patient and they need support in order to do that.  Amanda: That's a great point.  Having previously worked as a genetic counsellor, also seeing patients with inherited cancer conditions, it really strikes you how individual each person's journey and decisions are.  They're thinking about all kinds of factors in their life or in their family's life.  Navigating through that and understanding do I have surgery or do I have screening and how do I make decisions about this is based on my previous experiences and so many other factors.  Having access to different sources of support to help people navigate through that feels incredibly important.    We've been talking a bit about inherited cancers in general, but you're all here because you're involved in the CanGene-CanVar programme.  Kelly, could you tell us a bit more about what that is and what he programme is aiming to achieve?  Kelly: The CanGene-CanVar programme is a five year grant funded by Cancer Research UK.  It involves six different work packages, so lots of experts all around the UK have been allowed to have some dedicated time to work on specific areas where there hasn't been enough resource put in in the past which has resulted in a real gap between the research and the current findings and actually using that information to benefit patients by bridging the gap and putting those research findings into clinical care.    My programme is in work package four which is co-designing patient resources which are decision support interventions.  Basically, it's a website and it can be printed as a booklet and it's interactive and it's up to date and it's personalised to help convey the complicated information about genetic cancer conditions in a way that's meaningful and patients can understand, and it helps them with their personalised shared decision-making.  The CanGene-CanVar programme is underpinned by the patient reference panel and they've been involved, including Rochelle and others, from the conception of the idea of the programme and all the way through with various different activities helping to look at documents as they're developed, before their finalised, and giving input in focus groups and one-on-one and email conversations.  They're called upon frequently to share their lived experience and say what's important to them when they make decisions and that's really helped to drive the direction of the research and inform the results before they're published.     Amanda: That sounds like a really helpful approach to developing something in a way that's really working very closely with patients and participants.  Rochelle, it sounded like you were involved in that.  Can you tell us a bit about what that was like from your perspective?  Rochelle: It's really rewarding, it's really motivating to be actually one of the patient reps in relation to this.  I don't want to make my colleagues from the team blush, but it's just such an inclusive environment where as a patient is really welcomed, really heard, it's very much a partnership and that's been really, really important and it makes you feel valued as a patient and actually the importance of the lived experience the patient view has really been prominent in this.  I would say that's why it's helped develop such a useful tool, the fact as a patient people are really valuing and taking into account our lived experience, our views, our understanding.  It's been quite fun in some of the sessions.  There have been some good debates between us and some of the clinicians and it's been really good and really useful.  I think some of the people who maybe haven't encountered a patient panel before and engaged with patient's lived experience have probably learn a lot from it because we are pretty empowered to use our voice in this.  It's been a really great experience.   Amanda: I'd love to dig into those debates a bit more.  Kelly, were there things that you changed in the decision aid as a result of some of those discussions or as a result of that input that maybe surprised you?   Kelly: We have made changes based directly on what we've learned from the patients presenting their lived experiences.  They've been very open and honest with us.  Like Rochelle, I felt so privileged to be part of this real partnership with the patients.  As a genetic counsellor who had many years of experience in clinical practice before moving into this research role, I've been really surprised but also gratified by how much I've been able to learn from the patients in a different way because I am sort of taking a step back, I'm there as a researcher and not directly as a clinician looking after someone one-on-one in clinic and just thinking about their specific needs at that time.  But because I'm hearing from people from all different situations, different parts of the UK and other countries and maybe it's 10/20 years since they had their genetic diagnosis are actually getting a bigger picture of their care needs that we might not have heard about as the clinicians on the ground because they might not be coming back to tell us.  If we haven't opened the door to that conversation about their personal situation or who's influencing them or what's important to them when they make decisions, we just might not have learned about the thing they're grappling with and they've gone off and maybe Googled, they've found a patient support group or something else to support them.    In my research and in my interviews and the focus groups, all of the activities I've been learning about the gaps in care, what might be needed to address that.  The decision aid has not been yet ruled into clinical practice but we're very keen to get it out there and everyone wants it and wants to use it.  We want to make sure that we've developed it in a robust patient-centred way as much as we can for us before we put it out.  It will always be updated and go through refinements, but hopefully in the New Year we will be able to let people start using it in the real world situation.  Amanda: That's great, I'm sure you're looking forward to that.  Helen: I was just going to add to that in terms of the guideline development we've had a number of consensus meetings where we've made decisions about guidelines, for example, genes that can be predisposed to ovarian cancer and we've included patients from the patient reference panel and from other patient groups in those consensus meetings.  Again, as Kelly said, that's been so helpful because it's really brought something to those discussions and it is a different perspective than when we see patients in clinic because often we're seeing them at the point of genetic testing or maybe for their results, but actually that doesn't give us that overview of the whole patient journey and the whole patient experience.  I think that has been really one of the benefits of this programme and Kelly has been really pioneering the co-design of patient information leaflets, decision aids with patients.  Rather than clinicians designing things for patients that we think that they will understand, it's actually working with patients from the start to get things right the first time.  It's been a really great part of this programme.  Amanda: Rochelle, did you want to add something further here?   Rochelle: Yes.  I think one of the sessions that we had as a patient and clinician and researcher session that really stood out for me was when we started looking at how do people make decisions. We had academics and researchers who've looked at how do people make decisions, talk about the knowledge base and the research base that we have about it.  As a larger group of patients we got together to discuss about how have we made decisions.  It was really interesting because I don't think I've ever reflected on how I made the decision and what came from that in terms of what I did about having my mutation.  Hearing about how other people did as well, that session really does stick in my mind and actually I learnt a lot as a person about decision-making theory but also about myself and reflecting on how I make decisions.  So as a patient involved in this, it's not always about what I bring to this but actually as a patient rep you get a lot from it, too.  I've learnt a lot from the colleagues that I've worked with.  Amanda: That's fantastic.  It's really great to hear the careful thought that's gone into this, a real excellent example that hopefully others can look to.  I think, Kelly, hasn't your work won an award recently as well?  Kelly: We as a whole team won an award from the academic health science network and the NHS Confederation, it's called the Innovate Awards 2023.  This was for excellence in patient and public involvement in transformation and innovation.  Yes, it was a chance to showcase the really positive experience that we've had.  I think on all sides we've learnt a lot from each other and just to hope to inspire other researchers and clinicians to take this co-design approach with patients because we all benefit from it so much.  We think that the resources, the guidelines, everything that we develop will be better from the start if we work together throughout the project.    We're really hoping to encourage others to consider from the beginning of their idea about a research programme or clinical development to bring the patients in right at the start, because they can really help to guide where things go next and then throughout.  Even through to publications being on, committees, being co-chairs, presenting together at conferences, that can all help to really share the experience and the benefits that we get from the partnership.  Amanda: That's great, congratulations.  Coming back now to some of the aims of CanGene-CanVar and trying to bridge that gap, as you said, between research and clinical care, I guess that means there are some needs that still aren't being met that are falling through that gap at the moment.  Helen, from your perspective what are some of those unmet needs that we currently have or areas that are still needing improvement?    Helen: I think there's still lots that we have to learn, particularly about individual risks for patients.  We might have patients who all have a pathogenic variant in a certain gene but their risks might be slightly different due to factors that can modify their risk.  Trying to understand some of those risks better so that we can really have much better informed discussions with patients about their lifetime cancer risks I think would be really helpful.  Work package one of the programme is really focussing on that and looking at some of the information we have through national registries and trying to understand risks for specific genes better, which will help our discussions with patients, and then we still need to understand, which is more outside the programme, more how surveillance, so early cancer detection through screenings such as mammograms or ultrasounds for different cancers can help detect cancers early. There's still lots of information that we need to learn.    I think Kelly's decision aid which has been focussed on Lynch Syndrome, I think that can be translated across lots of other genetic conditions, because for each gene there is a different set of decisions.  For some of the genes that we developed clinical guidelines for we might be recommending slightly different management or for some of the genes we've recommended maybe a minimum and an extended level of surveillance, particularly for a gene called DICER1 where we've offered different options in childhood.  Decision aids would potentially help in some of those other genes building on the work that's already been developed as part of the programme.  Although the programme is coming to an end in the next year, I think there's still lots of work to be done in this area.   Amanda: It really sounds like you've all been collectively improving how much this work is worthwhile, so that's great to hear.  Rochelle, how about for you, are there areas that you would see as unmet needs or areas where we or research can improve to help patients and families with inherited cancers.  Rochelle: Similar to some of the stuff that Helen was saying, knowing more about what happens when people have different types of treatment, different types of surveillance and monitoring and stuff like that, I think there are things that are evolving all the time.  I think in the end when you think about gaps, there's nothing that's going to be written down on paper that says if you have this, do this.  In the end, every single patient is an individual with individual circumstances.  I think until we actually know that if you do this, this happens and this happens, this is going to be your chances of survival if you go through this route.  Even then when you've got the chance of survival, that's literally just a probability, it's not a binary this will happen or that will happen.  There's always going to be a need for discussion, there's always going to be a need for these brilliant genetic counsellors that we have to talk us through some of those complex decisions that we have to make.  I think, yes, we'll get more information, we'll get more evidence, we'll get more understanding of treatments that work best for different people, and we'll get it out there and we absolutely do need to do that.    Even when you have all the information you need, even if you made a solid decision, I mean, when I found out I had the mutation immediately I was like, right, that's it, I'll have preventative surgery after what happened to my mum.  It was an absolute no-brainer for me.  For other people it might not have been if they were at a different life stage.  I'd had my kids, I didn't need my ovaries, I didn't need my womb, it was pretty clear cut.  Even then when I was thinking about the different treatment and when to have that surgery, I got most of my information from bumping into somebody in the ladies' toilets who has been through it before.  I think there's always going to be a need in terms of being able to have those conversations to take in all the information you do that and make some sort of informed decision.  What came out of that decision-making workshop and all the other things that we did about probabilities, it's all just a model.  It's a model of what might happen.  The thing is, all of these models, they're all wrong, they just help you maybe make a discussion or a decision that might be right.  You just never know.  I still don't know if the decisions I made were the right decisions either.  There needs to be that space for people to consider their options, you're never going to get the definitive answer.    Amanda: An important message there.  We talk a lot about using digital tools to be able to do things better at scale, better ways to give information, but I think what you're saying is we can't replace certain elements of human connection, we can't underestimate the value of that.  You made a really good point earlier as well about how so many of these decisions have uncertainty and it can be really difficult to navigate the complexities of a health system.  Perhaps even more challenging if you have struggles with health literacy or if you are an underserved group in some way or another.     Kelly, I think you mentioned that some of your research has also touched on developing information for underserved groups.  Can you tell us a bit more about that?  Kelly: We recognised that there are many underserved groups that are not represented in research, in literature, and applied for additional funding to do some specific targeted projects in the community.  There were a couple of examples I can mention.  One was inspired by colleagues at the Royal Marsden who made some videos about prostate screening and the had black men and their family members talking about this in a relaxed barber's shop setting.  Through reaching out into the community I was connected with Lee Townsend from Macmillan who's been making these barbershop videos around London for the last seven years.  He's focussed on a number of topics like mental health, vaccination and cancer.  We connected and it was really about making that connection in the community, him as a trusted leader, and having formed partnerships with some of the barbers who opened up their barbershops for filming these sessions and went way beyond that.    One of them has actually trained as a counsellor himself because he said men are coming for a haircut and actually they have a bald head, they don't need the haircut, they're coming actually for the chat.  Because it's benefitting their mental health and they felt able to open up about topics that they wouldn't talk about even at home with their family members or with their friends, such as symptoms of cancer, going for cancer screening or presenting for treatment if they were symptomatic.  It's really powerful.  We've actually filmed six videos with black and minority ethnicity patients, talking about their cancer experience and they've really both helped others by setting an example that it's okay to talk about these things.  Also, through the process an added benefit was helping themselves, so it was peer support.  When they came to the barbershop to film their stories, they didn't need to stay for the whole time but they did stay for the three hours.  They said afterwards how helpful it was just to hear others in a similar situation sharing their stories.  One of them told me he's got up on stage and shared his cancer journey and he's been going to these patient groups and talking when he didn't feel able to do that in the past.  It's been a great project and we're going to be adding the videos to the CanGene-CanVar patient decision aid website soon.  Another thing that we've done in the diet and lifestyle section of the website where it talks about things that people might do to lower their chances of getting cancer have partnered with Professor Ranjit Manchanda who had some colleagues in India and made some infographics that specifically depict patients of a South Asian heritage and the types of foods that they might be choosing to give examples of how they might for example try to get more fibre in their diet to lower the chances of getting bowel cancer or trying to eat more fruits and vegetables or drink less alcohol.  It shows images of Indian patients.  What people have told me in my research, my interviews, focus groups, is they tend to go and try to search for something that means something to them, so they're looking for someone like me.  One of the patients I filmed she said that she had breast cancer as a young black woman and she was only middle-aged women on the websites.  She thought why is this, do black women not get breast cancer or young women like me?  For her to share her story was very brave but also has the potential to help a lot of other people in the community.   Amanda: That's really powerful, so understanding those nuances in different cultures or communities or groups is just so crucial to really being able to also develop information or messages or provide care that's going to really reach those people where they are, I guess.  This has been a really fantastic conversation.  If we could end with a final question, it would be great to hear from your perspective just one thing that you'd like to see in the next five to ten years when it comes to care for inherited cancer susceptibility conditions.  Helen, let's start with you?  Helen: I think that in developing the guidelines one of the things that we've had to struggle or grapple with is a lack of evidence and the lack of the data that's available for some of these conditions.  I'm really hoping that over the next five to ten years that we will see much more data on cancer risks and outcomes of surveillance progress for people who have an inherited predisposition.  Then we can utilise that information to be able to share with patients to enable them to make best decisions about their care.  There's a number of initiatives that are currently underway thinking about how we might better collect data on patients with inherited cancer predisposition in the UK, through registries, so I am really hoping that we manage to get some useful data that we can then use in our discussions with patients going forward.  Amanda: Thank you.  Kelly?  Kelly: I think that over the next five to ten years as awareness and availability of genetic testing continues to increase, we know that there will be more and more families identified who have a higher genetic risk of getting certain cancers.  We can't replace that personalised counselling that takes place, face-to-face or sometimes telephone and video appointments with a healthcare profession.  So there are more resources needed for the NHS to deliver this.  To compliment that, the patient website decision aid that we have co-designed is one way to help.  What patients tell us they would like, access to a central trusted source of information that's up to date.  Importantly in genetics it's very fastmoving, there's a lot of research, guidelines are changing, and it's very crucial to have information that's correct and relevant for people, and also meaningful.  We can only do that by partnering together with patients and co-designing things rather than designing them and asking them afterwards if they're useful.  It's a partnership all the way through that we all benefit from.    As I said earlier, it's not a one-size-fits-all, decision-making is so personal and shared decision-making is recommended but we don't always have enough time in clinic to really address all of the issues that the patient might not have even thought about themselves.  Having something like a patient-facing resource website booklet that they can look at in their own time, prepare for their questions that they really want to focus on in clinic, it might help give them the confidence to bring something up that they might not have otherwise.  It's about a number of different ways of helping to support people.  We've identified that there are gaps in care that we could try to help address if we have more resource in future.  Those are my aspirations.  Thank you, Amanda.   Amanda: Thank you.  And Rochelle, to you?  Rochelle: I think for me I would like to have as many people as possible to understand or know about their genetic mutation status.  We know people don't even know about the fact that they may have a genetic mutation that may make them more susceptible to cancers, and we know that even then if you do can you get access to testing to know whether you've got it or not.  That is the most important thing.  My mum, if she'd known that some of this was related, if she'd had that awareness that breast and ovarian cancer in your family was related to potential genetic risk, maybe she would have pushed harder to get testing and maybe she wouldn't have been tested when it's too late.  In the end, all this knowledge and empowering people with knowledge, whether that be about empowering people with the knowledge that they may have a genetic mutation, there's a possibility of the genetic mutation, that these things are related and empowering people through the knowledge of knowing their genetic mutation status, all that is something that saves lives.  From my view, it undoubtedly probably has saved my life and so my hope for the future is that we can empower more people like me and we can save more lives.   Amanda: Thank you for our guests today Dr Helen Hansen, Rochelle Gold and Kelly Kohut.  If you enjoyed today's episode, we'd love your support.  Please subscribe to The G Word on your favourite podcast app and like, share and rate us wherever you listen.  I've been your host, Amanda Pichini.  This podcast was edited by Mark Kendrick at Ventoux Digital and produced by Naimah Callachand.  Thanks for listening.     

In this special episode, Matthew Taylor sits down with Sam Allen and Penny Pereira to explore the nuts and bolts of improvement at system level, its role in large-scale change and propelling transformation. Get to grips with improvement fundamentals, the factors needed for it to flourish and why building community is key to making it stick. This episode follows the launch of a new partnership between the NHS Confederation, Health Foundation and Q community to support health and care systems to learn and improve. Sam Allen is chief executive of North East and North Cumbria Integrated Care Board and Penny Pereira, managing director of Q at the Health Foundation. Hosted on Acast. See acast.com/privacy for more information.

The NHS has renewed its focus on improvement, with integrated care systems charged with becoming ‘self-improving systems' across England. While a necessary challenge, no other country in the world has undertaken improvement at this scale. In this episode, Matthew Taylor sits down with Prof Sir Chris Ham to unpack the system model of improvement – what it means, where it is working well and how it can shift the dial. It draws out key lessons from Sir Chris' report, commissioned by the NHS Confederation, Health Foundation and Q community, on how to improve health and care at scale. Hosted on Acast. See acast.com/privacy for more information.

From the NHS Confederation's Health Beyond the Hospital conference, Matthew Taylor hosts a discussion on out-of-hospital care and how novel collaborative approaches can lead to unexpected benefits. Coinciding with the launch of our report Unlocking the Power of Health Beyond the Hospital, Matthew is joined by Daniel Elkeles, chief executive of the London Ambulance Service NHS Trust, Karen Jackson, chief executive of Locala Community Partnerships CIC, Miriam Deakin, director of policy and strategy at NHS Providers and James Sanderson, director of community health services and personalised care at NHS England. Hosted on Acast. See acast.com/privacy for more information.

Martha Mills died after failures in her treatment at King's College Hospital. Martha's mother, Merope, is calling for hospitals around the country to bring in "Martha's rule", which would give parents, carers and patients the right to call for an urgent second clinical opinion from other experts at the same hospital if they have concerns about their current care. The government has said it will explore the introduction of Martha's rule in UK hospitals. Today's Nick Robinson spoke to Dr Sanjiv Sharma, Medical Director at Great Ormond Street Hospital and Matthew Taylor, Chief executive of the NHS Confederation. Nick Robinson also spoke to Sir Robert Francis, chair of the Francis Report and chair of the Freedom to Speak Up Review, published in 2015. (Image, Merope and Martha Mills, Credit Merope Mills)

Nikki Fox and Emma Tracey, who are standing in for Adam, speak to actor and SNP member Brian Cox about Nicola Sturgeon's departure, and who he would like to see in charge of the party. And as Rishi Sunak travels to Belfast to discuss the Northern Ireland Protocol, they get the latest on developments from Ireland correspondent Chris Page. More NHS strikes have been announced for March. Baron Victor Adebowale, Chair of the NHS Confederation, talks about how they could be resolved. Today's episode was presented by Nikki Fox and Emma Tracey and was made by Chris Flynn with Rufus Gray, Cordelia Hemming and Miranda Slade. The technical producer is Mike Regaard. The assistant editor is Verity Wilde.

Nikki Fox and Emma Tracey, who are standing in for Adam, speak to actor and SNP member Brian Cox about Nicola Sturgeon's departure, and who he would like to see in charge of the party. And as Rishi Sunak travels to Belfast to discuss the Northern Ireland Protocol, they get the latest on developments from Ireland correspondent Chris Page. More NHS strikes have been announced for March. Baron Victor Adebowale, Chair of the NHS Confederation, talks about how they could be resolved. Today's episode was presented by Nikki Fox and Emma Tracey and was made by Chris Flynn with Rufus Gray, Cordelia Hemming and Miranda Slade. The technical producer is Mike Regaard. The assistant editor is Verity Wilde.

The NHS Confederation says the service has entered "dangerous territory", members of the armed forces have been put on standby to cover for the action

Roy Lilley started his first enterprise from scratch over half a century ago. In 1989, his multi-million pound business was sold to fellow directors and managers. As a policy advisor and visiting fellow at Imperial College, London, he helped start the Health Services Management School at Nottingham University and was founder of the Federation of NHS Trusts, which became today's NHS Confederation. For over ten years now, Roy has written an e-letter (a bitesize podcast series) that reaches 300,000 health and care managers in the UK and overseas. A former chairman of Homewood NHS Trust in Surrey and former mayor of his borough council there, Roy Lilley has a wealth of public administration experience and has written for the Guardian, the Sunday Times, the Daily Telegraph and a number of other newspapers and periodicals. He is also a regular columnist in Pharmaceutical Marketing Magazine. He is a refreshingly honest and open man and willing to debate issues thoroughly. His enthusiasm and passion for the National Health Service is clear for all to see, and his comparative knowledge of healthcare systems is instructive; for example, he points out that Britain has proportionally far less management in healthcare than France or the USA. In a relaxed and frank interview, UK Column Nursing Correspondent Debi Evans talks to Roy about the current crisis in the NHS. Debi, a retired State Registered Nurse and a self-described old-school Ward Sister, also served for five years as a UK Government Advisor at the Department of Health and Social Care. Her conversation with Roy goes back to the days when hospitals were places full of flowers, nurses attended the sick in starched uniforms, and relatives were the real ‘regulators'; and when smiles, reassurance and tender loving care was a given, free at the point of contact. Fast forward to 2022 and digitisation, artificial intelligence and data gathering appears to have taken over from good old healthcare. Gone are the days when a nurse would hold your hand and take your pulse; today, you're likely to be scanned with an iPad. What is the state of the health of the NHS? Will the NHS Long Term Plan work? Is the NHS in a terminal condition, or can it be saved? If it can be saved, who will save it? This is the first of a series of interviews with Roy Lilley. UK Column looks forward to the next instalment of the Roy and Debi's common-sense NHS conversations. 

Three times voted the top speaker on NHS topics, Roy Lilley visits more than 20 NHS establishments a year and travels the UK and the world talking about healthcare, management and policy.

 He says, "Healthcare is my interest, my challenge, my passion and I am lucky to be involved with the professionals who make our lives healthier, our families safer and each of us proud of what we do."

Health bosses are warning of a "public health emergency" and a rise in excess winter deaths unless the government takes action to help people deal with rising energy prices.The NHS Confederation which represents health service managers in England, Wales and Norther Ireland says that with annual energy bills going up to £3,600 a year October – before increasing again in April - more people will be forced to choose between heating and eating.They say this will lead to more illness and – quotes – intolerable pressure on front line NHS staff.Adrian Goldberg hears from Dr Sonia Adesara, a GP in London and Byline Times Chief social affairs reporter Sian Norris.Produced by Adrian Goldberg and Harvey White.Funded by subscriptions to the Byline Times.Originally broadcast via Twitter Spaces @bylineradio Our GDPR privacy policy was updated on August 8, 2022. Visit acast.com/privacy for more information.

Dr Layla McCay asks us to think again about how our buildings and towns can both benefit and harm our mental health. As a trained psychiatrist and head of the Centre for Urban Design she has brought together the research around this topic for the first time. Looking at how plants and water can reduce the risk of psychosis and ‘bumping' places, where people can casually meet to form connections and potentially ease depression. Layla's work as the Director of the NHS Confederation has convinced her of the importance of design and physical health but also how little attention has been paid to it's impact on the mind. She says the concept of ‘restorative cities' - those that help heal or calm the mind are what we should be aiming for. Designing places that help counter loneliness, improve connections and keep depression at bay. Post Pandemic can we redesign our surroundings to support a happier and healthier life? Presenter Olly Mann Producer- Jordan Dunbar Editor- Tara McDermott

Oxford University economist Kate Raworth has been described by the author and environmentalist George Monbiot as, "The John Maynard Keynes of the 21st century." In 2018, she came to Intelligence Squared to talk through the set of ideas that has seen her influential book, Donut Economics, find fans in audiences ranging from members of the UN General Assembly to Pope Francis and Extinction Rebellion. Hosting the discussion was Matthew Taylor, at the time of the interview Chief Executive of the RSA and latterly Chief Executive of the NHS Confederation. Learn more about your ad choices. Visit megaphone.fm/adchoices

London was at the UK epicentre of the pandemic in 2020. Amid the suffering it was a time when profound questions were asked about how we might live better: economically and politically, culturally and spiritually, individually and collectively. What does a healthy society look like now? Panellists are: Deborah Bull - Vice President, Communities & National Engagement and the Senior Advisory Fellow for Culture at King's College London; Crossbench Peer. Stephanie Flanders - Senior Executive Editor for Economics at Bloomberg News and Head of Bloomberg Economics. Victor Adebowale - Chair of Social Enterprise UK and the NHS Confederation; Crossbench Peer; Co-founder of Visionable and a Governor at the London School of Economics. Chaired by Sarah Mullally, Bishop of London. St Paul's Cathedral runs a year-round social justice and Christian spirituality programme, in person and online. We are very grateful to Benefact Trust for their generous support of this programme and to CCLA for their support and partnership in this event. If you would like to join our mailing list to be the first to hear about upcoming events, please go to https://www.stpauls.co.uk/events-spirituality-and-social-justice

— When a child or teen is struggling with autism or their mental health, it impacts the entire family. That's why Meliora Health takes a family-first care approach to support your child's—and your family's—wellness journey. Their innovative online platform delivers immediate support and gives your entire family access to expert-led help whenever and wherever you need it, allowing your family to move forward together. As part of the UK's Healios Group, they've helped thousands of families struggling with mental health and neurodiverse conditions, and they can help yours too. Valeria Interviews Rich Andrews  — He Is The Founder And CEO Of Healios (UK) And Meliora Health (USA). Having close family and friends who've suffered from mental health conditions and dementia, Rich experienced first-hand the challenge of accessing support for both those affected by the condition and the families involved. In 2013, he founded Healios to tackle the global inequality of healthcare provision affecting over one billion people worldwide with mental health and neurodevelopmental conditions.  His passion for combining overall wellbeing, science and technology has led him to develop innovative services that optimize the ‘human touch' in the delivery of care to empower people and their families to live healthier and happier lives. This has led Healios to become the digital leader in the delivery of specialist mental health and neurodiverse clinical services for children and young people. Healios has now expanded into the US, with its US subsidiary operations under the brand name Meliora Health.   Prior to founding Healios, Rich gained knowledge and experience of global healthcare environments and health inequalities from an international career spanning over a decade working in biotech companies. Rich is a Board member of the Mental Health Network at the UK's NHS Confederation and co-chairs their national Digital Mental Health Forum. He is also an avid investor in start-up businesses that have a clear societal impact.  To learn more about Rich Andrews and his work, please visit: meliora-health.com and healios.org.uk    — This podcast is a quest for well-being, a quest for a meaningful life through the exploration of fundamental truths, enlightening ideas, insights on physical, mental, and spiritual health. The inspiration is Love. The aspiration is to awaken new ways of thinking that can lead us to a new way of being, being well.  

This live podcast was recorded at the Byline Festival in Notting Hill - I was joined by Dr Julia Grace Patterson, Lord Victor Adebowale, and Lorraine Collins. Dr Julia Grace Patterson is the founder and chief executive of Every Doctor, a campaign group advocating for better working conditions for NHS staff and her team have worked tirelessly to protect the well-being and future of doctors and nurses across the country. Lord Victor Adebowale is the chair of the NHS Confederation and has worked extensively in the field of health inequalities. My third panelist, Lorraine Collins is a psychotherapist and qualified cognitive-behavioral therapist. Her work in mental health proved to be extremely challenging throughout the pandemic. We all believe there are many lessons to be learned since the start of the pandemic. More importantly, is enough being done or are we just receiving empty promises from our ministers and leaders? Make sure you follow and support Dr Julia Grace Patterson, Lord Victor Adebowale and Lorraine Collins - they're doing some incredible work! A huge thank you to the team at Byline and Byline Festival for all their hard work to make this happen!

Over the past 20 years, our workplaces have changed for the better. The MeToo movement and Black Lives Matter have brought harassment and discriminatory actions to the fore, and our workplaces have generally become less tolerant of bad behaviour. But there's another highly damaging aspect of workplace culture that often goes unchecked - workplace bullying. As members of the UK political class come under fire for bullying their staff, Matthew Taylor is putting bullying in the spotlight. Matthew Taylor is the Chief Executive of the NHS Confederation, author of the Taylor Review into Modern Workplace Practices, and has spent many years thinking about creating safer environments for the future of our workforce. Despite his extensive grounding in tackling workplace culture, when he fell victim to poor treatment at work, it took him a long time to realise that what he was experiencing was bullying. Anxiety, self-doubt and isolation meant that he never did anything about it at the time, but it set him on a path of thinking about this prevalent and hidden issue. The pandemic has given many of us a chance to consider what we want from our working lives, and the so-called “Great Resignation” has brought new demands on employers to provide positive, meaningful working environments for their employees. Given the big shifts that are happening in employment, Matthew brings new perspectives and solutions to the table which are aiming to ensure that the future of work is better than the environments many of us work in today. Is bullying an inevitable part of a stressful and high-pressure work environment or is the fundamental way many workplaces are organised and managed a breeding ground for bullying? Matthew examines how work culture and the law could radically change to help prevent it. Presenter: Matthew Taylor Producer: Emma Barnaby Executive Producer: Katherine Godfrey Sound Designer and Mix Engineer: Rob Speight A Novel production for BBC Radio 4

Welcome to Oven-Ready HR Reheated!We're giving listeners the opportunity for an extra slice of interviews from the first six episodes of Season 2 of the Oven-Ready HR Podcast.This compilation episode features:Matthew Taylor the newly appointed CEO of the NHS Confederation and the author of the eponymous Taylor Report on how some entrepreneurs exploit gig economy workers;Dr Sam Farley, a lecturer at Leeds University Business School whose research into the dark side of workplace behaviours reveals discusses the rise of cyberbullying;Award-winning journalist Reeves Wiedeman reveals the extraordinary ability of former WeWork CEO Adam Neumann to motivate his employees;Hype-Handbook Michael F Schein pours gentle scorn on some of HR and Management's favourite thinkers;Jeremy Hunt MP the UK's former Health and Foreign Secretary gives his opinion on flexible working from Day 1 of employment and the high prevalence of incidents of bullying and toxic work cultures within the NHS;Michael Whitfield the former CEO and co-founder of Thomson Benefits Online and now serial HR tech investor for his take on what makes a successful organisational culture.To hear the full interviews, simply visit ovendreadyhr.com!